

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cAMP-mediated signaling (GO:0043951) | 6.29370447 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.29169609 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.29169609 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.88657450 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.86799651 |
| 6 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.78093965 |
| 7 | negative thymic T cell selection (GO:0045060) | 5.39295516 |
| 8 | negative T cell selection (GO:0043383) | 5.36657226 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.15458148 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.09124007 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.84990096 |
| 12 | sphingosine metabolic process (GO:0006670) | 4.82115171 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.57587333 |
| 14 | activated T cell proliferation (GO:0050798) | 4.53259960 |
| 15 | positive regulation of granulocyte differentiation (GO:0030854) | 4.44977126 |
| 16 | positive T cell selection (GO:0043368) | 4.40950825 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.27602078 |
| 18 | T cell selection (GO:0045058) | 4.26225227 |
| 19 | tolerance induction (GO:0002507) | 4.23165993 |
| 20 | diol metabolic process (GO:0034311) | 4.20687272 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.17744770 |
| 22 | thymic T cell selection (GO:0045061) | 4.16992651 |
| 23 | response to interleukin-15 (GO:0070672) | 4.14317851 |
| 24 | negative regulation of T cell mediated immunity (GO:0002710) | 4.08916831 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.06207286 |
| 26 | negative regulation of glycoprotein metabolic process (GO:1903019) | 4.01386317 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.92693987 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90351386 |
| 29 | regulation of protein glycosylation (GO:0060049) | 3.85694214 |
| 30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.83581021 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.83344684 |
| 32 | signal complex assembly (GO:0007172) | 3.82364871 |
| 33 | leukocyte aggregation (GO:0070486) | 3.80519730 |
| 34 | regulation of regulatory T cell differentiation (GO:0045589) | 3.78294226 |
| 35 | opioid receptor signaling pathway (GO:0038003) | 3.76655867 |
| 36 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.72048662 |
| 37 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.68431552 |
| 38 | sphingoid metabolic process (GO:0046519) | 3.55894766 |
| 39 | T cell migration (GO:0072678) | 3.54344747 |
| 40 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.36931417 |
| 41 | regulation of T cell tolerance induction (GO:0002664) | 3.34703167 |
| 42 | B cell receptor signaling pathway (GO:0050853) | 3.31607845 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.31215071 |
| 44 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.23179311 |
| 45 | regulation of granulocyte differentiation (GO:0030852) | 3.21981758 |
| 46 | interferon-gamma secretion (GO:0072643) | 3.19710759 |
| 47 | piRNA metabolic process (GO:0034587) | 3.18663472 |
| 48 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09468053 |
| 49 | interferon-gamma production (GO:0032609) | 3.08566591 |
| 50 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.06588675 |
| 51 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.95317553 |
| 52 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.94264876 |
| 53 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.94264876 |
| 54 | modulation by symbiont of host immune response (GO:0052553) | 2.94264876 |
| 55 | positive regulation by symbiont of host defense response (GO:0052509) | 2.94264876 |
| 56 | modulation by symbiont of host defense response (GO:0052031) | 2.94264876 |
| 57 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.94264876 |
| 58 | regulation of defense response to virus by virus (GO:0050690) | 2.94100071 |
| 59 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.92514901 |
| 60 | positive regulation of isotype switching (GO:0045830) | 2.91895171 |
| 61 | regulation of tolerance induction (GO:0002643) | 2.91145818 |
| 62 | regulation of B cell differentiation (GO:0045577) | 2.89642461 |
| 63 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88837771 |
| 64 | positive regulation of humoral immune response (GO:0002922) | 2.84645622 |
| 65 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.84633667 |
| 66 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83466409 |
| 67 | behavioral response to ethanol (GO:0048149) | 2.83172649 |
| 68 | positive regulation of B cell differentiation (GO:0045579) | 2.80738771 |
| 69 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.80457937 |
| 70 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.80015870 |
| 71 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.79562316 |
| 72 | positive regulation of T cell mediated immunity (GO:0002711) | 2.79359874 |
| 73 | T cell receptor signaling pathway (GO:0050852) | 2.78778813 |
| 74 | negative regulation of interleukin-12 production (GO:0032695) | 2.77997565 |
| 75 | alpha-beta T cell differentiation (GO:0046632) | 2.77449266 |
| 76 | regulation of T cell mediated immunity (GO:0002709) | 2.76086299 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 2.75452663 |
| 78 | regulation of isotype switching (GO:0045191) | 2.74334009 |
| 79 | positive regulation of interleukin-4 production (GO:0032753) | 2.73978638 |
| 80 | positive regulation of tolerance induction (GO:0002645) | 2.72332540 |
| 81 | negative regulation of adaptive immune response (GO:0002820) | 2.72316594 |
| 82 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.71109403 |
| 83 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.70799884 |
| 84 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.69936292 |
| 85 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.69936292 |
| 86 | cellular extravasation (GO:0045123) | 2.69789863 |
| 87 | histone H3-K4 trimethylation (GO:0080182) | 2.69672785 |
| 88 | mast cell activation (GO:0045576) | 2.68856060 |
| 89 | myeloid dendritic cell activation (GO:0001773) | 2.68826012 |
| 90 | alpha-beta T cell activation (GO:0046631) | 2.68636567 |
| 91 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.68517193 |
| 92 | histone H3-K4 methylation (GO:0051568) | 2.68218235 |
| 93 | regulation of interleukin-5 production (GO:0032674) | 2.67506064 |
| 94 | macrophage activation involved in immune response (GO:0002281) | 2.66755737 |
| 95 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.61679809 |
| 96 | histone H3-K36 demethylation (GO:0070544) | 2.61497118 |
| 97 | positive regulation of DNA recombination (GO:0045911) | 2.59491782 |
| 98 | positive regulation of interleukin-2 production (GO:0032743) | 2.56016488 |
| 99 | T cell homeostasis (GO:0043029) | 2.55927811 |
| 100 | response to muramyl dipeptide (GO:0032495) | 2.54823371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.69090252 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.65219077 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.84499364 |
| 4 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.54936708 |
| 5 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.27633923 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25338778 |
| 7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 3.16189776 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70671811 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.69232920 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.48341715 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.46084634 |
| 12 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.40864879 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.24360100 |
| 14 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16376193 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15250082 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.14578778 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.08035494 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.06584842 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.06529481 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.03777485 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.03086979 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.02666239 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.00098118 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89733372 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86617710 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84290830 |
| 27 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.76043280 |
| 28 | MAF_26560356_Chip-Seq_TH2_Human | 1.75096885 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.73164194 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.71434544 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70250976 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63515713 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.63409817 |
| 34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61777766 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58586654 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55105709 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53514591 |
| 38 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51522273 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51315118 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45448653 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42560963 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42202607 |
| 43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41727929 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37231023 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36929503 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35980264 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31007856 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29846408 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29014914 |
| 50 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28373384 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23440914 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22672894 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22636637 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21614210 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19798062 |
| 56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16491530 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16442130 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15188809 |
| 59 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12136431 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11824988 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10376961 |
| 62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09191900 |
| 63 | GATA3_26560356_Chip-Seq_TH1_Human | 1.07361204 |
| 64 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.06917740 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05804006 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04264331 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01114276 |
| 68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00557113 |
| 69 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00270543 |
| 70 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.99303021 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98103189 |
| 72 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97083307 |
| 73 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.96959185 |
| 74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96803715 |
| 75 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.96569344 |
| 76 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.96125838 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93207287 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92079195 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91842425 |
| 80 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.91477121 |
| 81 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90905615 |
| 82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90713989 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89921712 |
| 84 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89616971 |
| 85 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88371199 |
| 86 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87319560 |
| 87 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87119857 |
| 88 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87074983 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86988900 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86224186 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85068214 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84152271 |
| 93 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.83857763 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83136756 |
| 95 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.82993627 |
| 96 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.82917964 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82454891 |
| 98 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.82454891 |
| 99 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81956373 |
| 100 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.81714614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.98913650 |
| 2 | MP0003724_increased_susceptibility_to | 2.97303967 |
| 3 | MP0009278_abnormal_bone_marrow | 2.93522960 |
| 4 | MP0005671_abnormal_response_to | 2.76250948 |
| 5 | MP0003436_decreased_susceptibility_to | 2.72795026 |
| 6 | MP0001800_abnormal_humoral_immune | 2.68718393 |
| 7 | MP0003045_fibrosis | 2.55920840 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.54100986 |
| 9 | MP0004381_abnormal_hair_follicle | 2.53598052 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.43328613 |
| 11 | MP0002653_abnormal_ependyma_morphology | 2.30350873 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.24655121 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.19373323 |
| 14 | MP0002723_abnormal_immune_serum | 2.16985098 |
| 15 | MP0001819_abnormal_immune_cell | 2.14191288 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.11459335 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.05771620 |
| 18 | MP0003866_abnormal_defecation | 2.04285159 |
| 19 | MP0000703_abnormal_thymus_morphology | 2.03418149 |
| 20 | MP0000685_abnormal_immune_system | 2.03040415 |
| 21 | MP0005387_immune_system_phenotype | 1.96600734 |
| 22 | MP0001790_abnormal_immune_system | 1.96600734 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.92302783 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.91253847 |
| 25 | MP0005025_abnormal_response_to | 1.90410600 |
| 26 | MP0002398_abnormal_bone_marrow | 1.88637867 |
| 27 | MP0008260_abnormal_autophagy | 1.86051578 |
| 28 | MP0002419_abnormal_innate_immunity | 1.84955259 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.84157396 |
| 30 | MP0000716_abnormal_immune_system | 1.79940408 |
| 31 | MP0005075_abnormal_melanosome_morpholog | 1.79442992 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.72922848 |
| 33 | MP0003303_peritoneal_inflammation | 1.72049796 |
| 34 | MP0005310_abnormal_salivary_gland | 1.68590016 |
| 35 | MP0003787_abnormal_imprinting | 1.65622969 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.61265047 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.59600636 |
| 38 | MP0002722_abnormal_immune_system | 1.58315141 |
| 39 | MP0003329_amyloid_beta_deposits | 1.54834113 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.54267129 |
| 41 | MP0004859_abnormal_synaptic_plasticity | 1.52881572 |
| 42 | MP0009785_altered_susceptibility_to | 1.52823743 |
| 43 | MP0003879_abnormal_hair_cell | 1.49978985 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.46576167 |
| 45 | MP0006082_CNS_inflammation | 1.43363163 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 1.41602773 |
| 47 | MP0009764_decreased_sensitivity_to | 1.41514508 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.39789642 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.35879811 |
| 50 | MP0002405_respiratory_system_inflammati | 1.35375903 |
| 51 | MP0003221_abnormal_cardiomyocyte_apopto | 1.34673200 |
| 52 | MP0002429_abnormal_blood_cell | 1.34551174 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.33900230 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.32507282 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.29227996 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.29227996 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.28555875 |
| 58 | MP0000604_amyloidosis | 1.18505694 |
| 59 | MP0004883_abnormal_blood_vessel | 1.17833592 |
| 60 | MP0002132_abnormal_respiratory_system | 1.16112909 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.15540958 |
| 62 | MP0001851_eye_inflammation | 1.14025921 |
| 63 | MP0004947_skin_inflammation | 1.11255203 |
| 64 | MP0001873_stomach_inflammation | 1.11001591 |
| 65 | MP0002928_abnormal_bile_duct | 1.09677968 |
| 66 | MP0001533_abnormal_skeleton_physiology | 1.08849439 |
| 67 | MP0004142_abnormal_muscle_tone | 1.07927749 |
| 68 | MP0008874_decreased_physiological_sensi | 1.07528803 |
| 69 | MP0005171_absent_coat_pigmentation | 1.01388852 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.00974861 |
| 71 | MP0003646_muscle_fatigue | 0.99864446 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.99639820 |
| 73 | MP0003635_abnormal_synaptic_transmissio | 0.95823607 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.93856355 |
| 75 | MP0003690_abnormal_glial_cell | 0.93855988 |
| 76 | MP0004130_abnormal_muscle_cell | 0.93791668 |
| 77 | MP0008569_lethality_at_weaning | 0.92881223 |
| 78 | MP0003880_abnormal_central_pattern | 0.92266452 |
| 79 | MP0001968_abnormal_touch/_nociception | 0.91400442 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 0.91203626 |
| 81 | MP0004742_abnormal_vestibular_system | 0.87294899 |
| 82 | MP0001501_abnormal_sleep_pattern | 0.86860359 |
| 83 | MP0005083_abnormal_biliary_tract | 0.84994921 |
| 84 | MP0008469_abnormal_protein_level | 0.83354754 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.81879192 |
| 86 | MP0002063_abnormal_learning/memory/cond | 0.81204550 |
| 87 | MP0000681_abnormal_thyroid_gland | 0.78801237 |
| 88 | MP0002933_joint_inflammation | 0.78313488 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.77275758 |
| 90 | MP0003091_abnormal_cell_migration | 0.76867225 |
| 91 | MP0001486_abnormal_startle_reflex | 0.76110300 |
| 92 | MP0009745_abnormal_behavioral_response | 0.74900957 |
| 93 | MP0002168_other_aberrant_phenotype | 0.73310448 |
| 94 | MP0005334_abnormal_fat_pad | 0.71703376 |
| 95 | MP0002064_seizures | 0.71418904 |
| 96 | MP0003136_yellow_coat_color | 0.71055038 |
| 97 | MP0008057_abnormal_DNA_replication | 0.64230294 |
| 98 | MP0003959_abnormal_lean_body | 0.63434603 |
| 99 | MP0005670_abnormal_white_adipose | 0.62462345 |
| 100 | MP0005423_abnormal_somatic_nervous | 0.61830963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.89782932 |
| 2 | Thyroid-stimulating hormone excess (HP:0002925) | 4.84059796 |
| 3 | Stomatitis (HP:0010280) | 4.48452993 |
| 4 | Myositis (HP:0100614) | 4.28331065 |
| 5 | Focal motor seizures (HP:0011153) | 4.27498129 |
| 6 | T lymphocytopenia (HP:0005403) | 4.22766827 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.12875674 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.03943721 |
| 9 | Spontaneous hematomas (HP:0007420) | 3.88025392 |
| 10 | Abnormality of T cell number (HP:0011839) | 3.86403991 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.75545662 |
| 12 | Orchitis (HP:0100796) | 3.53501040 |
| 13 | Peripheral hypomyelination (HP:0007182) | 3.41918601 |
| 14 | Optic neuritis (HP:0100653) | 3.35810358 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.35810358 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.08487511 |
| 17 | Pustule (HP:0200039) | 3.04236335 |
| 18 | Amelogenesis imperfecta (HP:0000705) | 3.01781172 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 2.96724877 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.96491567 |
| 21 | Abnormality of T cells (HP:0002843) | 2.91751338 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 2.91222870 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.91190827 |
| 24 | Autoimmune hemolytic anemia (HP:0001890) | 2.72389584 |
| 25 | Volvulus (HP:0002580) | 2.72310078 |
| 26 | Amyotrophic lateral sclerosis (HP:0007354) | 2.71383518 |
| 27 | IgM deficiency (HP:0002850) | 2.69443143 |
| 28 | Chest pain (HP:0100749) | 2.64969201 |
| 29 | Abnormality of macrophages (HP:0004311) | 2.61414468 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.59385389 |
| 31 | Parakeratosis (HP:0001036) | 2.59042512 |
| 32 | Recurrent skin infections (HP:0001581) | 2.58399261 |
| 33 | Encephalitis (HP:0002383) | 2.56480978 |
| 34 | Broad alveolar ridges (HP:0000187) | 2.56112100 |
| 35 | Stomach cancer (HP:0012126) | 2.51711316 |
| 36 | Ankle clonus (HP:0011448) | 2.51476901 |
| 37 | Progressive inability to walk (HP:0002505) | 2.46893222 |
| 38 | Basal cell carcinoma (HP:0002671) | 2.45715511 |
| 39 | Slow saccadic eye movements (HP:0000514) | 2.44467657 |
| 40 | Vasculitis (HP:0002633) | 2.42320350 |
| 41 | Meningitis (HP:0001287) | 2.35707680 |
| 42 | Verrucae (HP:0200043) | 2.33348069 |
| 43 | Papilloma (HP:0012740) | 2.33348069 |
| 44 | Leukocytosis (HP:0001974) | 2.32258295 |
| 45 | Prolonged bleeding time (HP:0003010) | 2.30139813 |
| 46 | Agitation (HP:0000713) | 2.29466780 |
| 47 | Postural instability (HP:0002172) | 2.28701618 |
| 48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.27809639 |
| 49 | Episodic fever (HP:0001954) | 2.27598727 |
| 50 | Dialeptic seizures (HP:0011146) | 2.25314340 |
| 51 | Chronic diarrhea (HP:0002028) | 2.25058280 |
| 52 | Abnormality of the columella (HP:0009929) | 2.22360198 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.21142089 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.21142089 |
| 55 | Papilledema (HP:0001085) | 2.18837265 |
| 56 | Recurrent viral infections (HP:0004429) | 2.18449938 |
| 57 | Obstructive lung disease (HP:0006536) | 2.17947718 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17947718 |
| 59 | Hemoptysis (HP:0002105) | 2.17041672 |
| 60 | Increased IgM level (HP:0003496) | 2.14144099 |
| 61 | Epistaxis (HP:0000421) | 2.13767945 |
| 62 | Colitis (HP:0002583) | 2.10862843 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.10489672 |
| 64 | Lymphopenia (HP:0001888) | 2.09779813 |
| 65 | Focal seizures (HP:0007359) | 2.09657166 |
| 66 | Severe combined immunodeficiency (HP:0004430) | 2.08950873 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.08632376 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.06724522 |
| 69 | Gastrointestinal inflammation (HP:0004386) | 2.05585245 |
| 70 | Gangrene (HP:0100758) | 2.05481081 |
| 71 | Recurrent sinusitis (HP:0011108) | 2.05468056 |
| 72 | Abnormality of the fingertips (HP:0001211) | 2.04509305 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.03667469 |
| 74 | Gingivitis (HP:0000230) | 2.03637473 |
| 75 | Gingival bleeding (HP:0000225) | 1.99654215 |
| 76 | Abnormality of the aortic arch (HP:0012303) | 1.99173069 |
| 77 | Tented upper lip vermilion (HP:0010804) | 1.98157283 |
| 78 | Abnormality of T cell physiology (HP:0011840) | 1.97049636 |
| 79 | IgG deficiency (HP:0004315) | 1.95524026 |
| 80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.93177242 |
| 81 | Sepsis (HP:0100806) | 1.91930830 |
| 82 | Cellulitis (HP:0100658) | 1.91721263 |
| 83 | Keratoconjunctivitis (HP:0001096) | 1.90989639 |
| 84 | Spastic gait (HP:0002064) | 1.90218834 |
| 85 | Abnormality of eosinophils (HP:0001879) | 1.89647044 |
| 86 | Granulocytopenia (HP:0001913) | 1.89607373 |
| 87 | Keratitis (HP:0000491) | 1.88857302 |
| 88 | Amaurosis fugax (HP:0100576) | 1.87808732 |
| 89 | Truncal obesity (HP:0001956) | 1.86829489 |
| 90 | Acute hepatic failure (HP:0006554) | 1.86720280 |
| 91 | Arterial thrombosis (HP:0004420) | 1.86118321 |
| 92 | Subacute progressive viral hepatitis (HP:0006572) | 1.84735215 |
| 93 | Acanthocytosis (HP:0001927) | 1.84037108 |
| 94 | Hypoplasia of the thymus (HP:0000778) | 1.81008875 |
| 95 | Memory impairment (HP:0002354) | 1.79695517 |
| 96 | Hypochromic anemia (HP:0001931) | 1.75476722 |
| 97 | Eosinophilia (HP:0001880) | 1.74850602 |
| 98 | Pulmonary embolism (HP:0002204) | 1.72817517 |
| 99 | Urticaria (HP:0001025) | 1.71383138 |
| 100 | Gaze-evoked nystagmus (HP:0000640) | 1.70439351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 4.38549570 |
| 2 | MAP4K1 | 3.43753890 |
| 3 | RIPK4 | 2.68750209 |
| 4 | SIK3 | 2.58190726 |
| 5 | PRPF4B | 2.35137054 |
| 6 | TXK | 2.34097077 |
| 7 | FES | 2.29554470 |
| 8 | SIK2 | 2.24269279 |
| 9 | STK38 | 2.23090746 |
| 10 | CAMKK2 | 2.13935604 |
| 11 | STK38L | 1.89378886 |
| 12 | NLK | 1.83965456 |
| 13 | ITK | 1.76426259 |
| 14 | KSR2 | 1.73854421 |
| 15 | ADRBK2 | 1.70696348 |
| 16 | CAMKK1 | 1.69913530 |
| 17 | BLK | 1.66019486 |
| 18 | ZAP70 | 1.56027717 |
| 19 | MAP4K2 | 1.55708560 |
| 20 | GRK6 | 1.55387100 |
| 21 | ERN1 | 1.53407457 |
| 22 | CDK19 | 1.53065491 |
| 23 | TAOK3 | 1.49858786 |
| 24 | IRAK4 | 1.42707627 |
| 25 | HCK | 1.42504048 |
| 26 | BTK | 1.41624635 |
| 27 | IKBKE | 1.36475875 |
| 28 | MAP3K13 | 1.35085457 |
| 29 | CSK | 1.31207561 |
| 30 | TYK2 | 1.30257712 |
| 31 | JAK3 | 1.29821648 |
| 32 | PASK | 1.28953438 |
| 33 | FRK | 1.23932070 |
| 34 | MARK2 | 1.23640436 |
| 35 | MELK | 1.22749340 |
| 36 | LCK | 1.17783434 |
| 37 | CAMK4 | 1.16742681 |
| 38 | TNK2 | 1.15714321 |
| 39 | TYRO3 | 1.15217731 |
| 40 | SYK | 1.15161638 |
| 41 | MAP2K7 | 1.06706220 |
| 42 | JAK1 | 1.05281345 |
| 43 | IRAK1 | 1.03706872 |
| 44 | EPHB1 | 1.02943616 |
| 45 | PRKD2 | 1.02837539 |
| 46 | MAP3K4 | 1.00271005 |
| 47 | UHMK1 | 0.98164716 |
| 48 | TEC | 0.97929369 |
| 49 | MAP2K2 | 0.97235426 |
| 50 | RET | 0.95798889 |
| 51 | MAP2K3 | 0.94841012 |
| 52 | JAK2 | 0.94333926 |
| 53 | FGFR4 | 0.92239347 |
| 54 | PRKD3 | 0.91657751 |
| 55 | PDK1 | 0.89882861 |
| 56 | NTRK2 | 0.89226754 |
| 57 | PDPK1 | 0.88199056 |
| 58 | CSF1R | 0.87893587 |
| 59 | PINK1 | 0.86810244 |
| 60 | MARK3 | 0.86057932 |
| 61 | LYN | 0.84566880 |
| 62 | LATS2 | 0.84142621 |
| 63 | GRK7 | 0.83444941 |
| 64 | MAP3K9 | 0.83302230 |
| 65 | ACVR1B | 0.79942936 |
| 66 | CDK12 | 0.77637808 |
| 67 | MAP3K6 | 0.76253724 |
| 68 | BCR | 0.75868954 |
| 69 | DYRK1B | 0.73674718 |
| 70 | MAP3K1 | 0.73133917 |
| 71 | FGFR3 | 0.69338922 |
| 72 | EPHA3 | 0.68782651 |
| 73 | ADRBK1 | 0.67213704 |
| 74 | MAPK11 | 0.67167968 |
| 75 | MAP3K7 | 0.61181959 |
| 76 | MAPK13 | 0.56456441 |
| 77 | MAP3K14 | 0.56151821 |
| 78 | FGR | 0.55591585 |
| 79 | TGFBR2 | 0.53003510 |
| 80 | TBK1 | 0.52698302 |
| 81 | IKBKB | 0.52553709 |
| 82 | MAP3K10 | 0.52055791 |
| 83 | TAOK1 | 0.49841284 |
| 84 | MAP3K2 | 0.48361753 |
| 85 | YES1 | 0.47742852 |
| 86 | MAPK12 | 0.46858883 |
| 87 | STK11 | 0.43839121 |
| 88 | KSR1 | 0.42287148 |
| 89 | PRKD1 | 0.42011027 |
| 90 | PIM1 | 0.41945942 |
| 91 | MAPK7 | 0.41774171 |
| 92 | PRKCH | 0.40914889 |
| 93 | GRK5 | 0.40463464 |
| 94 | MAP3K3 | 0.39330706 |
| 95 | IRAK3 | 0.38428450 |
| 96 | NEK6 | 0.37961458 |
| 97 | CDK4 | 0.37909716 |
| 98 | CSNK1A1L | 0.37396617 |
| 99 | PKN2 | 0.36607036 |
| 100 | MAP2K4 | 0.36223762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.62267785 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.49401768 |
| 3 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.40340396 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28013583 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.09848511 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.03166834 |
| 7 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.91535031 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90615186 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.90390220 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.87811167 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.64860227 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.58698035 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58185146 |
| 14 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.56587113 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.55657078 |
| 16 | Nicotine addiction_Homo sapiens_hsa05033 | 1.54619769 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53604535 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52562801 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51274806 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.46951502 |
| 21 | Colorectal cancer_Homo sapiens_hsa05210 | 1.46940884 |
| 22 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.40517609 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.39032738 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.38630190 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38488989 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36353532 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.32081441 |
| 28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.31061721 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30056701 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29796771 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.24947478 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.19556848 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19202383 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.15030735 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.12529983 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11105947 |
| 37 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.10325655 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09887231 |
| 39 | GABAergic synapse_Homo sapiens_hsa04727 | 1.08130727 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06815994 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05994140 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04836062 |
| 43 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.04475655 |
| 44 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.01752236 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00278497 |
| 46 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.99619346 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.98763603 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 0.98180189 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98005099 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96854774 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.96382004 |
| 52 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92917559 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90605520 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89986943 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89761038 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89666110 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88175343 |
| 58 | Endocytosis_Homo sapiens_hsa04144 | 0.87064932 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85648548 |
| 60 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.84958309 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84045224 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83437659 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82602938 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.81128428 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79125676 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78938922 |
| 67 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78539518 |
| 68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77967118 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77691802 |
| 70 | Olfactory transduction_Homo sapiens_hsa04740 | 0.75680835 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74451885 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73972086 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73881557 |
| 74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73603854 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.72986924 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69704911 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.69584533 |
| 78 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69262128 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68758444 |
| 80 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68325406 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67002918 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62433647 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62228824 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.62198842 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.62036210 |
| 86 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.61989002 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61557894 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61222231 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59093397 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58950822 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57783842 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57187298 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.54002153 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53481025 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53289585 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51665668 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51645885 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49133808 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46163597 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46073614 |

